JP2019535828A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535828A5 JP2019535828A5 JP2019547566A JP2019547566A JP2019535828A5 JP 2019535828 A5 JP2019535828 A5 JP 2019535828A5 JP 2019547566 A JP2019547566 A JP 2019547566A JP 2019547566 A JP2019547566 A JP 2019547566A JP 2019535828 A5 JP2019535828 A5 JP 2019535828A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- kctc
- metabolic syndrome
- deposit number
- strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 6
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 5
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 5
- 235000013305 food Nutrition 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 3
- 239000004480 active ingredient Substances 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 claims 3
- 235000019253 formic acid Nutrition 0.000 claims 3
- 206010003210 Arteriosclerosis Diseases 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 241000194032 Enterococcus faecalis Species 0.000 claims 2
- 241000194031 Enterococcus faecium Species 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 241000191996 Pediococcus pentosaceus Species 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 229940032049 enterococcus faecalis Drugs 0.000 claims 2
- 208000023589 ischemic disease Diseases 0.000 claims 2
- 208000019423 liver disease Diseases 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160154978A KR101912774B1 (ko) | 2016-11-21 | 2016-11-21 | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 |
| KR10-2016-0154978 | 2016-11-21 | ||
| PCT/KR2017/013297 WO2018093238A2 (ko) | 2016-11-21 | 2017-11-21 | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535828A JP2019535828A (ja) | 2019-12-12 |
| JP2019535828A5 true JP2019535828A5 (enExample) | 2020-01-30 |
| JP7012736B2 JP7012736B2 (ja) | 2022-02-14 |
Family
ID=62145598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019547566A Active JP7012736B2 (ja) | 2016-11-21 | 2017-11-21 | ギ酸生成能に優れた菌株を有効成分として含む肥満または肥満によって惹起された代謝症候群の予防または治療用組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11564955B2 (enExample) |
| JP (1) | JP7012736B2 (enExample) |
| KR (1) | KR101912774B1 (enExample) |
| WO (1) | WO2018093238A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4074324A4 (en) * | 2019-10-24 | 2024-02-28 | Doctor TJ Co., Ltd. | COMPOSITION CONTAINING ENTEROCOCUS FAECALIS AS ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF OBESITY OR METABOLIC SYNDROMES INDUCED THEREBY |
| JP7153274B2 (ja) * | 2019-12-25 | 2022-10-14 | 京都府公立大学法人 | 慢性腎臓病進行抑制剤 |
| EP4082555A4 (en) * | 2019-12-27 | 2024-01-24 | National University Corporation Kobe University | AGENT FOR INHIBITING CAPILLARY BLOOD VESSEL DISORDER, AGENT FOR IMPROVING CAPILLARY BLOOD VESSEL DISORDER AND AGENT FOR ACCELERATING CAPILLARY BLOOD VESSEL DISORDER |
| KR102512802B1 (ko) * | 2020-04-21 | 2023-03-23 | 한국식품연구원 | 포름산 생성능이 우수한 엔테로코커스 패칼리스 tk1 균주, 이를 포함하는 항비만용 식품 조성물 및 이의 제조방법 |
| CN115245523A (zh) * | 2021-01-28 | 2022-10-28 | 上海市第六人民医院 | 青春双歧杆菌在制备脂肪吸收抑制剂中的应用 |
| CN114042091A (zh) * | 2021-10-24 | 2022-02-15 | 郑州大学 | 酪黄肠球菌在制备治疗代谢综合征产品中的应用方法 |
| CN115466689B (zh) * | 2022-02-09 | 2023-06-16 | 中国科学技术大学 | 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用 |
| IT202200013138A1 (it) * | 2022-06-22 | 2023-12-22 | Cerbios Pharma Sa | Probiotico per l’uso nel trattamento di alterazioni infiammatorie della mucosa intestinale, in particolare obesità |
| CN117625478A (zh) * | 2023-11-29 | 2024-03-01 | 广西爱生生命科技有限公司 | 一种具有治疗非酒精性脂肪肝和/或减脂功能的戊糖片球菌菌株a21243及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63280027A (ja) | 1987-05-11 | 1988-11-17 | Nichinichi Shokuhin Kk | 抗高脂血症剤 |
| US6787348B1 (en) * | 1998-08-26 | 2004-09-07 | Chr. Hansen | Liquid starter cultures having improved storage stability and use thereof |
| DE19854402A1 (de) | 1998-11-25 | 2000-05-31 | Hassan Jomaa | Verwendung von Phosphonameisensäurederivaten zur therapeutischen und prophylaktischen Behandlung von Infektionen |
| JP4666736B2 (ja) | 2000-09-05 | 2011-04-06 | 花王株式会社 | 高血圧症予防・改善・治療剤 |
| WO2005077390A1 (ja) | 2004-02-16 | 2005-08-25 | Yasuo Kawai | 血糖値低下剤、糖尿病治療・予防剤及びその製造方法 |
| JP5569710B2 (ja) * | 2009-02-27 | 2014-08-13 | 国立大学法人広島大学 | 肥満予防又は改善剤 |
| KR101271538B1 (ko) | 2011-06-24 | 2013-06-05 | (주)이뮤노텍 | 유기산, ｌ―카르니틴, ｌ―아르기닌 및 니코틴아미드를 유효성분으로 포함하는 비만의 예방 및 개선용 조성물 |
| EP2716167A1 (en) | 2012-10-02 | 2014-04-09 | Lunamed AG | Non-pharmaceutical composition comprising short chain fatty acids |
| KR101508586B1 (ko) * | 2013-10-21 | 2015-04-08 | 한국식품연구원 | 비만억제능이 우수한 신규한 엔테로코커스 휘칼리스 md366 균주 |
| KR20160066253A (ko) | 2014-12-02 | 2016-06-10 | (주)아모레퍼시픽 | 이카리시드 b2를 함유하는 대사 증후군 예방 또는 개선용 조성물 |
| KR101611829B1 (ko) * | 2015-06-08 | 2016-04-14 | 주식회사 쎌바이오텍 | 비만 및 비만으로 야기된 대사성 질환의 예방 또는 치료를 위한 페디오코커스 펜토사세우스 cbt sl4 균주 및 이를 포함하는 조성물 |
| CN109219656B (zh) | 2016-09-06 | 2025-12-09 | 深圳华大生命科学研究院 | 长栖粪杆菌（Faecalibacterium longum）及其应用 |
| EP3511407B1 (en) | 2016-09-06 | 2023-05-17 | BGI Shenzhen | Christensenella intestinihominis and application thereof |
-
2016
- 2016-11-21 KR KR1020160154978A patent/KR101912774B1/ko active Active
-
2017
- 2017-11-21 WO PCT/KR2017/013297 patent/WO2018093238A2/ko not_active Ceased
- 2017-11-21 US US16/462,901 patent/US11564955B2/en active Active
- 2017-11-21 JP JP2019547566A patent/JP7012736B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019535828A5 (enExample) | ||
| CN115135749B (zh) | 植物乳杆菌菌株及含有其的用于预防或治疗代谢疾病的组合物 | |
| Cani et al. | Novel opportunities for next-generation probiotics targeting metabolic syndrome | |
| Ebel et al. | Impact of probiotics on risk factors for cardiovascular diseases. A review | |
| CN115135750B (zh) | 发酵乳杆菌菌株及含有其的用于预防或治疗代谢疾病的组合物 | |
| Jonganurakkun et al. | Pediococcus pentosaceus NB-17 for probiotic use | |
| EP4484581A3 (en) | Akkermansia muciniphila eb-amdk19 strain and use thereof | |
| JP2019508486A5 (enExample) | ||
| JP2004524836A5 (enExample) | ||
| EP2917335B1 (en) | Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance | |
| JP2024523900A (ja) | 代謝性疾患の予防及び治療のためのラクトバチルスファーメンタム菌株及び制御性ｔ細胞の併用投与用途 | |
| WO2018093238A3 (ko) | 포름산 생성능이 우수한 균주를 유효성분으로 포함하는 비만 또는 비만으로 야기된 대사증후군의 예방 또는 치료용 조성물 | |
| KR102544149B1 (ko) | 락토바실러스 헬베티쿠스 균주 및 이를 포함하는 염증성 질환의 예방 또는 치료용 조성물 | |
| JP6989286B2 (ja) | 動脈硬化症を予防するためのプロバイオティクス組成物および方法 | |
| WO2022065330A1 (ja) | 筋委縮予防剤 | |
| JP2020513780A5 (enExample) | ||
| FI20075539A0 (fi) | Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia | |
| WO2016031880A1 (ja) | ビフィズス菌及びアブラナ科野菜を含有する経口組成物 | |
| RU2017138021A (ru) | Композиция для сокращения выработки кишечного газа | |
| JP2011246355A5 (enExample) | ||
| JP4604207B2 (ja) | 老化抑制作用を有する乳酸菌およびその用途 | |
| JP6491422B2 (ja) | 免疫疾患予防剤 | |
| Liao et al. | Lactobacillus reuteri GMNL-263 reduces hyperlipidaemia and the heart failure process in high-calorie diet-fed induced heart dysfunction in rats | |
| Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
| JP2018535940A5 (enExample) |